Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market
Posted inCorporations Drugs (Pharmaceuticals) Federal Courts (US) Federal-State Relations (US) Food and Drug Administration GenBioPro Inc Generic Brands and Products Mifeprex (RU-486) mifepristone Regulation and Deregulation of Industry Suits and Litigation (Civil)

Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market

The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
Goldman Sachs Earnings Disappoint Investors
Posted inBank of America Corporation Bank of New York Mellon Corporation Banking and Financial Institutions Bankman-Fried, Sam Bed Bath & Beyond Inc Carlson, Tucker Charles Schwab Corporation DeSantis, Ron Dominion Voting Systems Corp Federal Deposit Insurance Corp Federal Reserve System Fox News Channel Gensler, Gary S Glazer, Avram A Goldman Sachs Group Inc HK FTX Trading Ltd (Futures Exchange) House Financial Services Committee Huizenga, William P internal-storyline-no JPMorgan Chase & Company M&T Bank Corporation McHenry, Patrick T MillerKnoll Inc Musk, Elon OpenAI Labs Regulation and Deregulation of Industry Robinhood Financial LLC Schwab, Charles R Silicon Valley Bank Twitter Walt Disney Company

Goldman Sachs Earnings Disappoint Investors

The Wall Street giant’s latest financial results show how its push into consumer banking remains a drag on its overall business.